Using AI to create personalized treatments for chronic rhinosinusitis.
Official title: The Chronic Rhinosinusitis (CRS) Problem and an AI Driven Personalized Medicine Solution
Funded at Indiana University Indianapolis · NIH-11023120 · Data updated 2026-11-12
This study is looking at how we can use artificial intelligence to create personalized treatment plans for people with chronic rhinosinusitis (CRS) to help improve their symptoms and overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | February 2, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $688,440 |
| NIH project number | 5R01AI175631-02 |
| Project ID | NIH-11023120 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 years old who are diagnosed with chronic rhinosinusitis and experience significant symptoms.
✕Less likely to help
Patients with acute rhinosinusitis or those who do not have chronic symptoms may not benefit from this research.
What this research studies
This research focuses on chronic rhinosinusitis (CRS), a common condition that significantly impacts quality of life due to symptoms like nasal blockage, loss of smell, and recurrent infections. The study aims to utilize artificial intelligence to analyze individual patient data and develop personalized treatment plans that address the unique disease trajectories of CRS patients. By understanding how CRS affects overall health and its relationship with other respiratory diseases, the research seeks to improve treatment outcomes and patient satisfaction. Patients will be closely monitored to assess the effectiveness of these tailored approaches over time.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients suffering from chronic rhinosinusitis.
How similar studies have gone: Previous research has shown promise in using AI for personalized medicine in other chronic conditions, indicating potential success for this approach in CRS.
Where this research is happening
-
Indiana University Indianapolis
Indianapolis, United States Active
Researchers
- Principal investigator: Ramakrishnan, Vijay — Indiana University Indianapolis
- Study coordinator: Ramakrishnan, Vijay
Related research
Other NIH-funded projects on the same topics.
-
AI-guided personalized care for chronic sinus inflammation
Using AI to personalize treatments for adults with chronic sinus inflammation so people get the therapies most likely to relieve their symptoms.
-
Triamcinolone-loaded nanocapsules after endoscopic nasal surgery
This trial tests whether a triamcinolone acetonide–loaded nanocapsule spray is better than saline irrigation for healing after endoscopic nasal surgery in adults with chronic rhinosinusitis and nasal polyps.
-
Smell training in CRS patients with smell loss
This study tests whether a 3-month smell training program can improve smell function and related immune and mental health measures in adults with chronic rhinosinusitis and smell loss.
-
PROPEL corticosteroid‑releasing sinus implants — IBUKI cohort
This project tests how safe and well PROPEL corticosteroid‑releasing sinus implants work for people in Japan with chronic rhinosinusitis who undergo endoscopic sinus surgery.
-
Lavender aromatherapy for anxiety and pain during awake ear, nose, and throat procedures
This tests whether lavender aromatherapy used during awake ear, nose, and throat clinic procedures can reduce anxiety and pain in adults.
-
Seawater nasal sprays for relief of nasal and sinus symptoms
This project will test four seawater nasal sprays to see if they help infants, children, adults, and pregnant or breastfeeding people with acute or chronic nasal and sinus symptoms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.